$SLS

4 theses

bullish 100%neutral 0%bearish 0%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Jun 10, 4:02 PM ET

$SLSYOLObullish

u/Bulls_Will_Win · 8d agono track record yet

Long 1799 shares of SLS

Here is what can still fail the SLS trial when success seems "guaranteed"

Author, a biomedicine professor, models the SLS trial using conservative Weibull methodology and estimates an 80% probability of success, 15% narrow miss, and 5% failure. Despite not being mathematically guaranteed, the expected upside from trial success and potential regulatory approvals justify current valuation; author holds 1799 shares.

At post $8.33Now $7.15-14.2% since postedas of Jun 10, 4:02 PM ET

1d-1.7%

3d-1.2%

1w-7.8%

1m—

3m—

6m—

1y—

original post →

$SLSGainbullish

u/winter-shoulders · 19d ago12 prior · awaiting results

Space is the place, man

SLS is positioned for very positive trial readout results in the coming months with 78 of 80 events reached. Author expects positive results and a potential buyout within the next year.

At post $7.78Now $7.15-8.1% since postedas of Jun 10, 4:02 PM ET

1d—

3d—

1w+19.7%

1m—

3m—

6m—

1y—

original post →

$SLSYOLObullish

u/HonestLiving08x · 21d agono track record yet

“full port, mix of call options with varying expirations (referenced leaps and closer-dated positions, screenshot shown but specific strikes/dates not legible in text)”

All in on cancer $SLS

SLS's GPS drug REGAL trial is near completion (78/80 events) and the author expects a positive outcome based on strong Phase 2 CR2 AML data showing 16.3 months vs 5.4 months median overall survival. Author is fully committed to the position, betting the trial success will drive stock sharply higher.

At post $8.97Now $7.15-20.3% since postedas of Jun 10, 4:02 PM ET

1d-15.7%

3d-13.3%

1w-4.3%

1m—

3m—

6m—

1y—

original post →

$SLSGainbullish

u/winter-shoulders · 33d ago12 prior · awaiting results

“LEAPS”

Options changed my life pt.5

SLS offers a high-risk, high-reward opportunity with potential 20x upside using LEAPS, representing a speculative bet on the company's success with binary outcome.

At post $5.01Now $7.15+42.7% since postedas of Jun 10, 4:02 PM ET

1d—

3d+4.8%

1w+41.3%

1m+64.3%

3m—

6m—

1y—

original post →

End of results.